Targacept, Inc. to Present at the Cowen and Company 33rd Annual Health Care Conference
Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that Dr. Stephen A. Hill, President and Chief Executive Officer, is scheduled to present at the Cowen and Company 33rd Annual Health Care Conference at The Boston Marriott Copley Place in Boston, Massachusetts on Tuesday, March 5, 2013 at 8:00 a.m. Eastern Time.